论文部分内容阅读
GADOLIN: Primary results from a phase Ⅲ study of obinutuzumab plus bendamustine compared with bendam
【作 者】
:
【机 构】
:
BC Cancer Agency, Vancouver, BC Department of Onc
【出 处】
:
2015年临床肿瘤学新进展学术研讨会
【发表日期】
:
2015年3期
其他文献
Phase Ⅲ trials of anamorelin in patients with advanced non-small cell lung cancer (NSCLC) and cachex
会议
Long-term safety of fertility preservation by ovarian stimulation and concurrent aromatase inhibitor
会议
Chemotherapy-related cognitive impairment (CRCI), and neurotransmitter signaling, longevity, and inf
会议
会议
A pharmacokinetically (PK) and pharmacodynamically (PD) driven phase I trial of the pan-AKT inhibito
会议
会议